IL-17 has pro- and anti-inflammatory properties. It induces neutrophil-mediated inflammation while also suppressing autoimmune diseases [46,47]. Importantly, studies investigating colorectal cancer have shown that IL-17 exhibits protumoral properties, especially during the early stages [47]. The gene discussed is IL17A; the disease is autoimmune disease.